These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3856466)

  • 1. Plasma membranes from normal and chronic myeloid leukemic granulocytes: isolation and two-dimensional polyacrylamide gel electrophoretic analysis.
    Zingde SM; Mungikar AM; Chhajlani V; Advani SH; Gothoskar BP
    Cancer Biochem Biophys; 1985 Feb; 7(4):333-42. PubMed ID: 3856466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct analysis of differentiation proteins in normal and leukemic human granulocytes by high-performance liquid chromatography.
    Evans WH; Bednarek JM; Alvarez VL; Wright DG; Terebelo HR; Taylor G
    J Natl Cancer Inst; 1985 Aug; 75(2):227-35. PubMed ID: 3860680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrophoretic heterogeneity of peripheral blood granulocytes in patients with chronic myeloid leukemia].
    Slivinskiĭ GG; Il'iasova MN; Kozhanova SV
    Eksp Onkol; 1987; 9(6):67-70. PubMed ID: 3481334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
    Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
    Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The receptor for IgG on human normal and chronic myeloid leukemic granulocytes: functional and biochemical characterization.
    Shirsat NV; Zingde SM; Advani SH; Gothoskar BP
    Cancer Biochem Biophys; 1989 May; 10(3):235-45. PubMed ID: 2528404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma membrane proteins from human normal and chronic myeloid leukemic granulocytes: identification and partial characterization of the concanavalin A-binding and detergent resistant proteins.
    Zingde SM; Advani SH; Gothoskar BP
    Blut; 1987 Aug; 55(2):89-100. PubMed ID: 3475139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monthly variations in ovine seminal plasma proteins analyzed by two-dimensional polyacrylamide gel electrophoresis.
    Cardozo JA; Fernández-Juan M; Forcada F; Abecia A; Muiño-Blanco T; Cebrián-Pérez JA
    Theriogenology; 2006 Sep; 66(4):841-50. PubMed ID: 16530261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of polypeptide composition of mature granulocytes obtained from patients with chronic myelogenous leukemia.
    Yokota J; Asano S; Teshima S; Morishita K; Iwamoto A; Yoshikura H; Miwa S
    Blood; 1982 Feb; 59(2):443-6. PubMed ID: 6948583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple forms of lactoferrin in normal and leukemic human granulocytes.
    Furmanski P; Li ZP
    Exp Hematol; 1990 Sep; 18(8):932-5. PubMed ID: 2201556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the relationship between the granulocyte LDH, alkaline phosphatase and Zn at the level of the leukocyte in patients with chronic myeloid leukemia.
    Chirulescu Z; Suciu A; Chiriloiu C; Pîrvulescu R; Micu D
    Med Interne; 1986; 24(3):221-5. PubMed ID: 3465014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of lysosomal acid-soluble proteins on the respiratory activity of the granulocytes of healthy subjects and chronic myeloid leukemia patients].
    Rybakova LP; Tiagotin IuV; Kharchenko MF
    Vopr Med Khim; 1981; 27(1):80-3. PubMed ID: 6936972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface membrane protein changes during the differentiation of cultured human promyelocytic leukemia HL-60 cells.
    Felsted RL; Gupta SK; Glover CJ; Fischkoff SA; Gallagher RE
    Cancer Res; 1983 Jun; 43(6):2754-61. PubMed ID: 6573952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of a novel glycoprotein from the urine of a patient with chronic myelocytic leukemia.
    Rudman D; Chawla RK; Del Rio AE; Hollins B
    J Clin Invest; 1974 Mar; 53(3):868-74. PubMed ID: 4204683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic determination of granulocyte alkaline phosphatase by the GEMSAEC.
    Crook L; Sarji NM; Liu PI; Gadsden RH; Williams TR
    Ann Clin Lab Sci; 1980; 10(3):198-203. PubMed ID: 6930935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane protein components of normal leukocytes and leukemic cells.
    Notario A; Ricetti M; Barbieri G
    Biochem Exp Biol; 1978; 14(2):149-58. PubMed ID: 288476
    [No Abstract]   [Full Text] [Related]  

  • 17. Aberrant sialylation of granulocyte membranes in chronic myelogenous leukemia.
    Baker MA; Taub RN; Whelton CH; Hindenburg A
    Blood; 1984 May; 63(5):1194-7. PubMed ID: 6585235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered isozyme patterns of leucocyte alkaline phosphatase in disease states.
    Miller DM; Yang A; Liepman M
    Br J Haematol; 1984 May; 57(1):145-54. PubMed ID: 6586202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alkaline phosphatase activity improved by the addition of zinc in granulocytes from leukemic subjects (in vitro study).
    Chirulescu Z; Chiriloiu C; Suciu A; Popescu M; Micu D
    Med Interne; 1984; 22(4):293-6. PubMed ID: 6595761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two-dimensional polyacrylamide gel electrophoresis-based serum protein separation: comparison of two sample preparation methods].
    Zhao L; Ding YQ; Liang L; Li X; Li XH; Wu LS
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):5-8. PubMed ID: 17259133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.